Healthy Adult MaleNCT07454265
Short-Term Broccoli Supplementation and Acute Oxidative Stress Recovery
A study testing Broccoli powder in people with Healthy Adult Male, run by Lithuanian Sports University at 1 site in Lithuania.
Trial summary
The study aimed to evaluate the effects of short-term broccoli powder supplementation on metabolically demanding exercise performance, muscle power, and blood lactate recovery. It also investigated broccoli powder-derived sulforaphane bioavailability and its effects in attenuating exercise-induced oxidative stress. Read more about this study
- Who is it for?
- Ages 18 to 37 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Healthy Adult Male
- What is being tested?
- Broccoli powder
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 17 participants
- Where
- 1 siteLithuania
- Study dates
- 30 Nov 2024to 10 Jan 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 37 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- males;
- age:18-37 years;
- no illnesses or injuries in the month preceding data collection and were engaged in organized physical activity no more than twice per week.
Who cannot join
- Non-compliance with the study protocol, illness, or injury during the study period.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Short-Term Broccoli Powder Supplementation on Acute Oxidative Stress and Recovery Following a Metabolically Demanding Exercise Session
The study aimed to evaluate the effects of short-term broccoli powder supplementation on metabolically demanding exercise performance, muscle power, and blood lactate recovery. It also investigated broccoli powder-derived sulforaphane bioavailability and its effects in attenuating exercise-induced oxidative stress. Seventeen healthy males (age 23.8 ± 4.9 years, height 182.3 ± 6.1 cm, weight 80.0 ± 12.8 kg), in a double-blind crossover design, three weeks apart, consumed ten standard doses of either broccoli powder or spinach powder as a placebo over a period of 2 weeks. They then performed a maximal progressive cycling task with concomitant analysis of expired gas composition. Plasma malondialdehyde (MDA) level was measured before and 60 min after the completion of the task, and blood lactate and muscle power (counter-movement vertical jump (CMJ) performance) were measured before and up to 60 min after exercise.
Read the detailed description
Intense exercise increases oxygen consumption and mitochondrial respiration, leading to elevated production of reactive oxygen species (ROS). While moderate ROS levels play an essential role in cellular signaling and training adaptation, excessive accumulation may overwhelm antioxidant defenses and promote oxidative damage to lipids, proteins, and nucleic acids. The balance between ROS production and endogenous antioxidant systems is therefore critical during and after strenuous exercise. Traditional antioxidant supplementation has produced inconsistent findings, with some evidence suggesting that high doses of exogenous antioxidants may blunt adaptive signaling. Consequently, attention has shifted toward nutritional strategies that enhance endogenous cytoprotective pathways rather than directly scavenging free radicals.
Broccoli is rich in glucoraphanin, the precursor of sulforaphane (SFN), a bioactive isothiocyanate formed through myrosinase-mediated hydrolysis. SFN activates the Nrf2 signaling pathway, upregulating phase II detoxifying and antioxidant enzymes such as heme oxygenase-1 and NAD(P)H quinone oxidoreductase-1, thereby strengthening intrinsic antioxidant defense mechanisms. Although sulforaphane has demonstrated cytoprotective and anti-inflammatory properties, its effects on exercise-induced oxidative stress in healthy, recreationally active individuals remain insufficiently characterized. The present study examined whether short-term broccoli powder supplementation enriched with myrosinase influences sulforaphane bioavailability, oxidative stress, performance, and recovery following metabolically demanding exercise.
Seventeen healthy young men (23.8 ± 4.9 years) completed a randomized, double-blind, placebo-controlled crossover study with a three-week washout period. Ethical approval was obtained from the Lithuanian Sports University Ethics Committee, and all participants provided written informed consent. Participants maintained habitual diet and physical activity and reported intake of caffeine, alcohol, cruciferous vegetables, and supplements prior to testing.
The intervention consisted of 10 g broccoli powder (99.5% broccoli powder, 0.5% mustard seed powder providing myrosinase; ~320 μg glucoraphanin per dose) mixed with 300 mL beverage. The placebo consisted of spinach powder prepared identically. Ten doses were consumed over 14 days, with the final dose ingested three hours before exercise testing.
Sulforaphane bioavailability was assessed from 24-hour urine collection after the first dose using liquid chromatography-mass spectrometry. The exercise protocol involved an incremental cycling test to voluntary exhaustion starting at 40 W with a ramp increase of 20 W per minute. Respiratory gases and heart rate were continuously measured, and VO₂max was determined as the highest 20-second average achieved, verified by standard physiological criteria.
Countermovement jump height was assessed before exercise and 1, 30, and 60 minutes post-exercise. Capillary blood lactate was measured pre-exercise and during recovery (1-60 minutes). Venous blood samples were collected before and one hour after exercise to determine plasma malondialdehyde concentration as a marker of lipid peroxidation. Data were analyzed using repeated measures ANOVA with statistical significance set at p < 0.05.
- Conditions
- Healthy Adult Male
- Being tested
- Broccoli powder, Placebo (no broccoli-derived bioactives)
- Keywords
- Sulforaphane, Bioavailability, Lactate, VO₂max
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Broccoli powderDietary supplement
The intervention consisted of a single 35-mL scoop of broccoli powder (BrocAffex; 99.5% broccoli powder and 0.5% mustard seed powder), corresponding to 10 g of supplement and delivering 320 μg of glucoraphanin per serving. The supplement was mixed with 300 mL of chocolate oat milk (13 participants) or 300 mL of orange juice (4 participants).
Placebo (no broccoli-derived bioactives)Dietary supplement
1/2 x 35 ml scoop of dried spinach powder blended with 300 ml of chocolate oat milk (13 participants) or orange juice (4 participants).
| Study group | Role | What they receive |
|---|---|---|
| male healthy volunteers aged 18-37 years | Experimental | Participants completed both conditions in a crossover design with washout. They consumed 10 g broccoli powder (~320 μg glucoraphanin) or matched spinach placebo for 14 days (10 doses), final dose 3 h pre-test. Receives: Dietary Supplement: Broccoli powder; Dietary Supplement: Placebo (no broccoli-derived bioactives) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sulforaphane, mg/24hours
Measured: Urine was collected over a 24-hours period following ingestion of the first supplementation dose in both conditions, and sulforaphane was subsequently extracted and analyzed up to one week after study completion.
Plasma malondialdehyde concentration, nmol/mL
Measured: Blood sample was collected before incremental cycling and 1 hour post-test in both conditions and plasma malondialdehyde concentration was subsequently analyzed up to one week after study completion.
Peak power output, Watts
Measured: During each experimental condition (at peak exercise during incremental ramp cycling test)
Maximal oxygen uptake, mL/min/kg
Measured: During each experimental condition (at peak exercise during incremental ramp cycling test)
Secondary outcomes (3)
Peak heart rate, beats per minute
Measured: During each experimental condition (at peak exercise during incremental ramp cycling test)
Blood lactate concentration, mmol/L
Measured: Capillary blood lactate was measured before the metabolically demanding exercise task, and then 1 minute, 3 minutes, 5 minutes, 30 minutes and 60 minutes post-exercise in both conditions.
Jump height, cm
Measured: Countermovement jump (CMJ) height was measured before (baseline), and then 1 minute, 30 minutes, and 60 minutes after the metabolically demanding exercise task in both conditions.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Mar 2026
- Study start30 Nov 2024
- Primary completion1 Jan 2025
- Study completion10 Jan 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy Adult MaleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 17 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lithuanian Sports University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sigitas Kamandulis, Dr., Principal investigator, Lithuanian Sports University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07454265
- Sponsor's protocol ID
- BI-TRS (M)-2024-703
- Status last verified
- Feb 2026
- First submitted
- 5 Feb 2026
- Last updated
- 6 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Short-Term Broccoli Powder Supplementation on Acute Oxidative Stress and Recovery Following a Metabolically Demanding Exercise Session
- ClinicalTrials.gov ID
- NCT07454265
- Acronym / sponsor ID
- BI-TRS (M)-2024-703
- Conditions
- Healthy Adult Male
- Keywords
- Sulforaphane, Bioavailability, Lactate, VO₂max
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 17 participants (actual)
- Lead sponsor
- Lithuanian Sports UniversityUniversity, hospital or other
- Study start
- 30 Nov 2024 (actual)
- Primary completion
- 1 Jan 2025 (actual)
- Study completion
- 10 Jan 2025 (actual)
- First posted
- 6 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study aimed to evaluate the effects of short-term broccoli powder supplementation on metabolically demanding exercise performance, muscle power, and blood lactate recovery. It also investigated broccoli powder-derived sulforaphane bioavailability and its effects in attenuating exercise-induced oxidative stress. Seventeen healthy males (age 23.8 ± 4.9 years, height 182.3 ± 6.1 cm, weight 80.0 ± 12.8 kg), in a double-blind crossover design, three weeks apart, consumed ten standard doses of either broccoli powder or spinach powder as a placebo over a period of 2 weeks. They then performed a maximal progressive cycling task with concomitant analysis of expired gas composition. Plasma malondialdehyde (MDA) level was measured before and 60 min after the completion of the task, and blood lactate and muscle power (counter-movement vertical jump (CMJ) performance) were measured before and up to 60 min after exercise.
Detailed description
Intense exercise increases oxygen consumption and mitochondrial respiration, leading to elevated production of reactive oxygen species (ROS). While moderate ROS levels play an essential role in cellular signaling and training adaptation, excessive accumulation may overwhelm antioxidant defenses and promote oxidative damage to lipids, proteins, and nucleic acids. The balance between ROS production and endogenous antioxidant systems is therefore critical during and after strenuous exercise. Traditional antioxidant supplementation has produced inconsistent findings, with some evidence suggesting that high doses of exogenous antioxidants may blunt adaptive signaling. Consequently, attention has shifted toward nutritional strategies that enhance endogenous cytoprotective pathways rather than directly scavenging free radicals.
Broccoli is rich in glucoraphanin, the precursor of sulforaphane (SFN), a bioactive isothiocyanate formed through myrosinase-mediated hydrolysis. SFN activates the Nrf2 signaling pathway, upregulating phase II detoxifying and antioxidant enzymes such as heme oxygenase-1 and NAD(P)H quinone oxidoreductase-1, thereby strengthening intrinsic antioxidant defense mechanisms. Although sulforaphane has demonstrated cytoprotective and anti-inflammatory properties, its effects on exercise-induced oxidative stress in healthy, recreationally active individuals remain insufficiently characterized. The present study examined whether short-term broccoli powder supplementation enriched with myrosinase influences sulforaphane bioavailability, oxidative stress, performance, and recovery following metabolically demanding exercise.
Seventeen healthy young men (23.8 ± 4.9 years) completed a randomized, double-blind, placebo-controlled crossover study with a three-week washout period. Ethical approval was obtained from the Lithuanian Sports University Ethics Committee, and all participants provided written informed consent. Participants maintained habitual diet and physical activity and reported intake of caffeine, alcohol, cruciferous vegetables, and supplements prior to testing.
The intervention consisted of 10 g broccoli powder (99.5% broccoli powder, 0.5% mustard seed powder providing myrosinase; ~320 μg glucoraphanin per dose) mixed with 300 mL beverage. The placebo consisted of spinach powder prepared identically. Ten doses were consumed over 14 days, with the final dose ingested three hours before exercise testing.
Sulforaphane bioavailability was assessed from 24-hour urine collection after the first dose using liquid chromatography-mass spectrometry. The exercise protocol involved an incremental cycling test to voluntary exhaustion starting at 40 W with a ramp increase of 20 W per minute. Respiratory gases and heart rate were continuously measured, and VO₂max was determined as the highest 20-second average achieved, verified by standard physiological criteria.
Countermovement jump height was assessed before exercise and 1, 30, and 60 minutes post-exercise. Capillary blood lactate was measured pre-exercise and during recovery (1-60 minutes). Venous blood samples were collected before and one hour after exercise to determine plasma malondialdehyde concentration as a marker of lipid peroxidation. Data were analyzed using repeated measures ANOVA with statistical significance set at p < 0.05.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| male healthy volunteers aged 18-37 years | Experimental | Dietary Supplement: Broccoli powder, Dietary Supplement: Placebo (no broccoli-derived bioactives)Participants completed both conditions in a crossover design with washout. They consumed 10 g broccoli powder (~320 μg glucoraphanin) or matched spinach placebo for 14 days (10 doses), final dose 3 h pre-test. |
Who may qualify
- Ages
- 18 to 37 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- males;
- age:18-37 years;
- no illnesses or injuries in the month preceding data collection and were engaged in organized physical activity no more than twice per week.
Key exclusion criteria (1 listed)
- Non-compliance with the study protocol, illness, or injury during the study period.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Broccoli powderThe intervention consisted of a single 35-mL scoop of broccoli powder (BrocAffex; 99.5% broccoli powder and 0.5% mustard seed powder), corresponding to 10 g of supplement and delivering 320 μg of glucoraphanin per serving. The supplement was mixed with 300 mL of chocolate oat milk (13 participants) or 300 mL of orange juice (4 participants). | Dietary supplement | male healthy volunteers aged 18-37 years |
| Placebo (no broccoli-derived bioactives)1/2 x 35 ml scoop of dried spinach powder blended with 300 ml of chocolate oat milk (13 participants) or orange juice (4 participants). | Dietary supplement | male healthy volunteers aged 18-37 years |
Primary outcome
Sulforaphane, mg/24hours
Time frame: Urine was collected over a 24-hours period following ingestion of the first supplementation dose in both conditions, and sulforaphane was subsequently extracted and analyzed up to one week after study completion.
Plasma malondialdehyde concentration, nmol/mL
Time frame: Blood sample was collected before incremental cycling and 1 hour post-test in both conditions and plasma malondialdehyde concentration was subsequently analyzed up to one week after study completion.
Peak power output, Watts
Time frame: During each experimental condition (at peak exercise during incremental ramp cycling test)
Maximal oxygen uptake, mL/min/kg
Time frame: During each experimental condition (at peak exercise during incremental ramp cycling test)
3 secondary outcomes
Peak heart rate, beats per minute
Time frame: During each experimental condition (at peak exercise during incremental ramp cycling test)
Blood lactate concentration, mmol/L
Time frame: Capillary blood lactate was measured before the metabolically demanding exercise task, and then 1 minute, 3 minutes, 5 minutes, 30 minutes and 60 minutes post-exercise in both conditions.
Jump height, cm
Time frame: Countermovement jump (CMJ) height was measured before (baseline), and then 1 minute, 30 minutes, and 60 minutes after the metabolically demanding exercise task in both conditions.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Healthy Adult Male
Not yet recruitingPhase 1
A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Cannabidiol Capsules (AVAT-121) and Epidyolex® in Healthy Adults
Focal Onset Seizure
Active, not recruitingPhase 1/2
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
RecruitingPhase 1/2
Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia
Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female
Recruiting
Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Brown Rice
Healthy Adult Males, Healthy Adult Females
RecruitingPhase 1
Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal Function
Renal Impairment, Healthy Volunteers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sigitas Kamandulis, Dr. principal investigator
Lithuanian Sports University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Broccoli powder in people with Healthy Adult Male, run by Lithuanian Sports University at 1 site in Lithuania.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Lithuania. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sulforaphane, mg/24hours (time frame: Urine was collected over a 24-hours period following ingestion of the first supplementation dose in both conditions, and sulforaphane was subsequently extracted and analyzed up to one week after study completion.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2026.